APEXIMMUNE THERAPEUTICS
Apeximmune Therapeutics engages in the discovery and development of novel biologics that modulate the immune system.
APEXIMMUNE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Diagnostics Life Science
Founded:
2018-01-01
Address:
Burlingame, California, United States
Country:
United States
Website Url:
http://www.apeximmune.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
Affivant
Affivant is committed to the development of novel immuno-oncology techniques that will stimulate and enable the innate immune system.
BiotechTown
BiotechTown is an integrated and private center for the development of scale-up biotechnology and life sciences businesses.
Facet Biotech
Facet Biotech engages in the identification and development of oncology drugs.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Employees Featured
Founder
Official Site Inspections
http://www.apeximmune.com Semrush global rank: 8.5 M Semrush visits lastest month: 523
- Host name: 3.3.180.107.host.secureserver.net
- IP address: 107.180.3.3
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Apeximmune Therapeutics"
Apeximmune-About Us
Apeximmune Therapeutics is pioneering a new generation of therapeutic antibodies and biologics that harness the power of the immune system to deliver curative treatments for cancer and โฆSee details»
Apeximmune Therapeutics - Crunchbase Company Profile & Funding
Organization. Apeximmune Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Apeximmune Therapeutics is โฆSee details»
Apeximmune Therapeutics - LinkedIn
Apeximmuneโs mission is to harness the power of the immune system to treat cancer and autoimmune disease. We focus on discovering and pioneering powerful therapeutic antibodies against ...See details»
Apeximmune 2025 Company Profile: Valuation, โฆ
Apeximmune General Information Description. Developer of novel biologics designed to modulate the immune system. The company's platform combines โฆSee details»
Apeximmune Therapeutics - 2025 Company Profile - Tracxn
4 days ago Apeximmune Therapeutics has raised a total funding of $27.3M over 3 rounds. Its first funding round was on Mar 12, 2021. Its latest funding round was a Series A round on Apr โฆSee details»
Apeximmune-Contact Us
Apeximmune Therapeutics 863A Mitten Rd. Unit 161, Burlingame, CA 94010 [email protected]See details»
Apeximmune Therapeutics - VentureRadar
Apeximmune seeks to be a preeminent leader in the discovery and development of novel biologics that modulate the immune system for the treatment of a broad spectrum of โฆSee details»
Li-Fen Lee - Founder & CEO @ Apeximmune Therapeutics
Primary Organization . Apeximmune Therapeutics . Gender Female; Li-Fen Lee is deeply versed in the fields of immunology and immuno-oncology (IO) and has successfully carried several โฆSee details»
Apeximmune Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Apr 4, 2025 Explore Apeximmune Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Immune System Diseases, Technology โฆSee details»
Apeximmune Therapeutics - Contacts, Employees, Board โฆ
Organization. Apeximmune Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. โฆSee details»
Apeximmune Therapeutics Announces Successful Close of Series A ...
Burlingame, CA โ March 31, 2025 โ Apeximmune Therapeutics, a biotechnology company pioneering next-generation immunotherapies, today announced the successful close of its โฆSee details»
Apeximmune Therapeutics Inc. - VentureRadar
Apeximmune is dedicated to developing monoclonal antibody immunotherapies to benefit cancer patients resistant to current standard-of-care treatments. We seek to discover the most โฆSee details»
Apeximmune Therapeutics Inc. Completes $6 Million Pre-A Series ...
Mar 12, 2021 About Apeximmune Therapeutics Founded in 2016, Apeximmune Therapeutics, Inc. is focused on modulating the tumor microenvironment to treat cancer through the โฆSee details»
Apeximmune Therapeutics, Inc. (Apeximmune Therapeutics, Inc.)
ไบ่งฃApeximmune Therapeutics, Inc. (Apeximmune Therapeutics, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็๏ผ็พ็ ้ขๅ:่ฟ็ค๏ผๅ ็ซ็ณป็ป็พ็ ๏ผๆๆฏๅนณๅฐ:ๅๅ ้ๆไฝ๏ผ่ฏ็ฉ:AI โฆSee details»
Immuno-oncology and Antibody Discovery - OCPD Opportunities โฆ
Apr 15, 2021 Apeximmune is a pre-clinical stage biotechnology start-up where we believe in harnessing the power of the immune system to treat and cure cancer. Based in South San โฆSee details»
Apeximmune-Science
Apeximmune has a diverse pipeline of immune oncology monoclonal antibody therapeutics under development. The AI-306 program targeting a novel myeloid-expressed immune suppressor is โฆSee details»
Apeximmune Therapeutics Inc. Completes $6 Million Pre-A Series ...
Mar 12, 2021 Founded in 2016, Apeximmune Therapeutics, Inc. is focused on modulating the tumor microenvironment to treat cancer through the discovery of novel therapeutic antibodies. โฆSee details»
Apeximmune-Careers
Apeximmune Therapeutics 863A Mitten Rd. Unit 161, Burlingame, CA 94010 [email protected]See details»
Home - AxImmune Inc. - AxImmune Inc.
Overview. Axโ101 is a small molecule immuno-oncology drug with potent anti-tumor activity when used as a single agent, dramatically reducing the size of lymphoma in some patients and โฆSee details»